Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease sickle cell anemia
Symptom C0020538|hypertension
Sentences 24
PubMedID- 19488751 Significant, independent associations were found with both elevated ldh concentration and degree of anemia, suggesting that hemolytic and other mechanisms contribute to pulmonary hypertension in patients with sickle cell disease.
PubMedID- 21732836 Background: the prevalence and characteristics of pulmonary hypertension in adults with sickle cell disease have not been clearly established.
PubMedID- 25710019 The cell-derived particles can be considered as potential biological biomarkers for vascular dysfunction and disease severity, being significantly increased in sickle cell disease patients with pulmonary hypertension, sickling crises, acute chest syndrome, stroke, history of thrombosis, or splenectomy, being positively correlated with aortic stiffness, pulmonary artery pressure, and tricuspid regurgitant velocity, and being negatively correlated with aortic distensibility .
PubMedID- 22029999 Pulmonary hypertension in sickle cell disease.
PubMedID- 25423000 Pulmonary hypertension in sickle cell disease.
PubMedID- 24515990 Hypoxic response contributes to altered gene expression and precapillary pulmonary hypertension in patients with sickle cell disease.
PubMedID- 22175008 Moreover, low erythrocyte gln may contribute to alterations in the erythrocyte redox environment and may play a role in hemolysis and pulmonary hypertension in patients with sickle cell disease .
PubMedID- 22030000 Pulmonary hypertension in sickle cell disease.
PubMedID- 23271856 Previous studies have reported abnormal pulmonary function and pulmonary hypertension among nigerians with sickle cell disease, but there is no report of interstitial lung disease among them.
PubMedID- 26270484 This study aimed to evaluate the characteristics and severity of pulmonary hypertension in patients with sickle cell disease using detailed echocardiography.
PubMedID- 24942020 Elevated tricuspid regurgitant velocity as a marker for pulmonary hypertension in children with sickle cell disease: less prevalent and predictive than previously thought.
PubMedID- 22654300 Uric acid as a potential biomarker of pulmonary arterial hypertension in patients with sickle cell disease.
PubMedID- 22029998 Pulmonary hypertension in sickle cell disease.
PubMedID- 22210808 Pulmonary hypertension in patients with sickle cell disease: not so frequent but so different.
PubMedID- 22829869 As such, upregulation of arginase activity and expression has been reported to play a role in various vascular pathologies, such as pulmonary hypertension associated with sickle cell disease ischemia-reperfusion, as well as various animal models of arterial hypertension, sexual arousal, diabetes , , .
PubMedID- 25398989 Vasculopathy and pulmonary hypertension in sickle cell disease.
PubMedID- 21510733 Pulmonary hypertension in children with sickle cell disease.
PubMedID- 22029997 Pulmonary hypertension in sickle cell disease.
PubMedID- 25696889 Pulmonary hypertension in sickle cell disease: diagnosis and management.
PubMedID- 26370739 Pulmonary endarterectomy as treatment for chronic thromboembolic pulmonary hypertension in sickle cell disease.
PubMedID- 26176970 Pulmonary hypertension in sickle cell disease.
PubMedID- 23893714 Pulmonary artery occlusion pressure may overdiagnose pulmonary artery hypertension in sickle cell disease.
PubMedID- 22029996 Pulmonary hypertension in sickle cell disease.
PubMedID- 20553267 Pulmonary hypertension in sickle cell disease children under 10 years of age.

Page: 1